• Featured Product
  • KD/KO Validated

BCL6 Rekombinanter Antikörper

BCL6 Rekombinant Antikörper für WB, IHC, FC (Intra), IP, Indirect ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human, Maus

Anwendung

WB, IHC, FC (Intra), IP, Indirect ELISA

Konjugation

Unkonjugiert

CloneNo.

3K6

Kat-Nr. : 81754-1-PBS

Synonyme

BCL-6, 3K6, B cell CLL/lymphoma 6, B cell lymphoma 6 protein, B-cell lymphoma 5 protein



Geprüfte Anwendungen

Produktinformation

81754-1-PBS bindet in WB, IHC, FC (Intra), IP, Indirect ELISA BCL6 und zeigt Reaktivität mit human, Maus

Getestete Reaktivität human, Maus
Wirt / Isotyp Kaninchen / IgG
Klonalität Rekombinant
Typ Antikörper
Immunogen BCL6 fusion protein Ag15519
Vollständiger Name B-cell CLL/lymphoma 6
Berechnetes Molekulargewicht 706 aa, 79 kDa
Beobachtetes Molekulargewicht 79-95 kDa
GenBank-ZugangsnummerBC150184
Gene symbol BCL6
Gene ID (NCBI) 604
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Protein-A-Reinigung
Lagerungspuffer PBS only
LagerungsbedingungenStore at -80°C. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

BCL6, a zinc finger transcription factor, contains an N-terminal BTB/POZ domain and C-terminal zinc finger DNA-binding motifs and represses transcription of a wide range of target proteins and microRNAs. BCL6 protein has been reported as a master regulator of B lymphocyte development and growth, and altered BCL6 protein expression was implicated in pathogenesis of diverse human hematologic malignancies, especially in the diffuse large B cell lymphoma (DLBCL). BCL6 is required for the development of T follicular helper T cells (TFH), a helper T cell subset required for the formation of mature and productive GCs. BCL6 has also been shown to play important regulatory roles in macrophages.